PWAC
BNTC icon

Private Wealth Advisors (California)’s Benitec Biopharma BNTC Stock Holding History

Private Wealth Advisors (California)’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-885
Closed -$49K – 101
2021
Q3 		$49K Hold
885
– – 0.01% 115
2021
Q2 		$64K Buy
+885
New +$69.2K 0.02% 94

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Private Wealth Advisors (California)'s BNTC Position: Q4 2021 in Review

Private Wealth Advisors (California) sold out of Benitec Biopharma (BNTC) in Q4 2021, closing a stake of 885 shares — an estimated $49K sold.

Private Wealth Advisors (California) first reported a position in BNTC in Q2 2021 and held it in 2 quarters. The position peaked at $64K in Q2 2021. 17 funds tracked by Wall St. Rank hold BNTC as of Q4 2021.

  • Private Wealth Advisors (California) reported no remaining Benitec Biopharma position as of Q4 2021 after selling out during the quarter.
  • Private Wealth Advisors (California) sold 885 Benitec Biopharma shares in Q4 2021, an estimated $49K.
  • Private Wealth Advisors (California) first reported a position in Benitec Biopharma in Q2 2021 and held it in 2 quarters.
  • Private Wealth Advisors (California)'s Benitec Biopharma position peaked at $64K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Benitec Biopharma as of Q4 2021.

Based on Private Wealth Advisors (California)'s 13F filing for Q4 2021, filed 11 Feb 2022.